Early detection of cardiac sarcoid lesions with 18F-fluoro-2-deoxyglucose positron emission tomography

Internal Medicine

Volumn 50, Issue 11, 2011, Pages 1207-1209

  Ohira, Hiroshi ^a   Tsujino, Ichizo ^a   Sato, Takahiro ^a   Yoshinaga, Keiichiro ^a   Manabe, Osamu ^a   Oyama, Noriko ^a   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

18F FDG PET; Cardiac sarcoidosis; MRI

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART SARCOIDOSIS; HUMAN; INTERMETHOD COMPARISON; LUNG SARCOIDOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS;

AGED; CARDIOMYOPATHIES; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS;

EID: 79958076982     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4813     Document Type: Article

References (17)

1. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)n-nh(3)/(18)f-fdg pet. J Nucl Med 44: 1030-1036, 2003.
2. 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45: 1989-1998, 2004.
3. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26: 1538-1543, 2005.
4. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 35: 933-941, 2008.
5. 18f-fdg pet-ct in the detection of cardiac sarcoidosis. J Nucl Cardiol 16: 801-810, 2009.
6. Hiraga H, Iwai K, Hiroe M, et al. Guidelines for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases. The Japanese Ministry of Health and Welfare, Tokyo, Japan, 23-24, 1993 (in Japanese).
7. Smedema JP, Reenaers V, Geukens R. Images in cardiology. Cardiac sarcoidosis in a 60 year old woman. Heart 92: 688, 2006.
8. 18f-fluorodeoxyglucose positron emission tomography: An autopsy case. Circulation 122: 535-536, 2010.
9. Takeda N, Yokoyama I, Hiroi Y, et al. Positron emission tomography predicted recovery of complete a-v nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 105: 1144-1145, 2002.
10. Tadamura E, Yamamuro M, Kubo S, et al. Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation 113: e771-e773, 2006.
11. Pandya C, Brunken RC, Tchou P, Schoenhagen P, Culver DA. Detecting cardiac involvement in sarcoidosis: A call for prospective studies of newer imaging techniques. Eur Respir J 29: 418-422, 2007.
12. Bartlett ML, Bacharach SL, Voipio-Pulkki LM, et al. Artifactual inhomogeneities in myocardial pet and spect scans in normal subjects. J Nucl Med 36: 188-195, 1995.
13. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocar-dial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 31: 1749-1756, 1990.
14. Johnson LA, Edsall JR, Austin JH, Ellis K. Pulmonary sarcoido-sis: could mycoplasma-like organisms be a cause? Sarcoidosis Vasc Diffuse Lung Dis 13: 38-42, 1996.
15. Bocart D, Lecossier D, De Lassence A, Valeyre D, Battesti JP, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 145: 1142-1148, 1992.
16. Mikami R, Sekiguchi M, Ryuzin Y, et al. Changes in the peripheral vasculature of various organs in patients with sarcoidosis--possible role of microangiopathy. Heart Vessels 2: 129-139, 1986.
17. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22: 234-235, 2005.